目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Cancer
1.2.2. Technology
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Cancer outlook
2.2.2. Technology outlook
2.2.3. Test Type outlook
2.2.4. End Use outlook
2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Hereditary Cancer Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements of genetic testing in cancer detection
3.2.1.2. Integration with precision medicine
3.2.1.3. Growing awareness through public and government initiatives
3.2.1.4. Rising prevalence of cancer
3.2.2. Market restraint analysis
3.2.2.1. High costs and limited insurance coverage
3.3. Hereditary Cancer Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis

Chapter 4. Hereditary Cancer Testing Market: Cancer Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hereditary Cancer Testing Market: Cancer Movement Analysis
4.3. Hereditary Cancer Testing Market Size & Trend Analysis, by cancer, 2018 to 2030 (USD Million)
4.4. Hereditary Cancer Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Lung Cancer
4.5.1. Lung Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Breast Cancer
4.6.1. Breast Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Colorectal Cancer
4.7.1. Colorectal Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Cervical Cancer
4.8.1. Cervical Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Ovarian Cancer
4.9.1. Ovarian Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Prostate Cancer
4.10.1. Prostate Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Stomach/Gastric Cancer
4.11.1. Stomach/Gastric Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Melanoma
4.12.1. Melanoma Market estimates and forecasts 2018 to 2030 (USD Million)
4.13. Sarcoma
4.13.1. Sarcoma Market estimates and forecasts 2018 to 2030 (USD Million)
4.14. Uterine Cancer
4.14.1. Uterine Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.15. Pancreatic Cancer
4.15.1. Pancreatic Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
4.16. Others
4.16.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Hereditary Cancer Testing Market: Technology Estimates & Trend Analysis
5.1. Technology Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Hereditary Cancer Testing Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Cytogenetic
5.5.1. Cytogenetic Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Biochemical
5.6.1. Biochemical Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Molecular Testing
5.7.1. Molecular Testing Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Test type Market: Test Type Estimates & Trend Analysis
6.1. Test type Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Test type Market by Capacity Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Predictive Testing
6.5.1. Predictive Testing Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Testing
6.6.1. Diagnostic Testing Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. End Use Market: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Global End Use Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Diagnostic Centers
7.5.1. Diagnostic Centers Market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Hospitals
7.6.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Clinics
7.7.1. Clinics Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Hereditary Cancer Testing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. North America: SWOT Analysis
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/Reimbursement
8.5.2.3. Competitive scenario
8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/Reimbursement
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Mexico
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/Reimbursement
8.5.4.3. Competitive scenario
8.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. Europe: SWOT Analysis
8.6.2. UK
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/Reimbursement
8.6.2.3. Competitive scenario
8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/Reimbursement
8.6.3.3. Competitive scenario
8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/Reimbursement
8.6.4.3. Competitive scenario
8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/Reimbursement
8.6.5.3. Competitive scenario
8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/Reimbursement
8.6.6.3. Competitive scenario
8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Norway
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework/Reimbursement
8.6.7.3. Competitive scenario
8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework/Reimbursement
8.6.8.3. Competitive scenario
8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.9. Denmark
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory framework/Reimbursement
8.6.9.3. Competitive scenario
8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Asia Pacific: SWOT Analysis
8.7.2. Japan
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/Reimbursement
8.7.2.3. Competitive scenario
8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/Reimbursement
8.7.3.3. Competitive scenario
8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. India
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/Reimbursement
8.7.4.3. Competitive scenario
8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework/Reimbursement
8.7.5.3. Competitive scenario
8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. South Korea
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework/Reimbursement
8.7.6.3. Competitive scenario
8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.7. Thailand
8.7.7.1. Key country dynamics
8.7.7.2. Regulatory framework/Reimbursement
8.7.7.3. Competitive scenario
8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Latin America: SWOT Analysis
8.8.2. Brazil
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/Reimbursement
8.8.2.3. Competitive scenario
8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Argentina
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework/Reimbursement
8.8.3.3. Competitive scenario
8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. MEA: SWOT Analysis
8.9.2. South Africa
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework/Reimbursement
8.9.2.3. Competitive scenario
8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework/Reimbursement
8.9.3.3. Competitive scenario
8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework/Reimbursement
8.9.4.3. Competitive scenario
8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key country dynamics
8.9.5.2. Regulatory framework
8.9.5.3. Competitive scenario
8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2024
9.3.4. Myriad Genetics, Inc.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Services benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Invitae Corporation
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Services benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Bio-Rad Laboratories
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Services benchmarking
9.3.6.4. Strategic initiatives
9.3.7. CSL Ltd
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Services benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Qiagen NV
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Services benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Danaher Corporation
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Services benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Thermo Fisher Scientific
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Services benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Abbott Laboratories
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Services benchmarking
9.3.11.4. Strategic initiatives
9.3.12. EUROFINS SCIENTIFIC
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Services benchmarking
9.3.12.4. Strategic initiatives
9.3.13. F. HOFFMANN-LA ROCHE LTD
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Services benchmarking
9.3.13.4. Strategic initiatives
9.3.14. Illumina, Inc.
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Services benchmarking
9.3.14.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 North America Hereditary cancer testing market, by region, 2018 - 2030 (USD Million)
Table 3 North America Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 4 North America Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 5 North America Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 6 North America Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 7 U.S Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 8 U.S Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 9 U.S Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 10 U.S Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 11 Canada Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 12 Canada Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 13 Canada Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 14 Canada Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 15 Mexico Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 16 Mexico Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 17 Mexico Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 18 Mexico Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 19 Europe Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 20 Europe Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 21 Europe Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 22 Europe Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 23 UK Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 24 UK Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 25 UK Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 26 UK Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 27 Germany Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 28 Germany Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 29 Germany Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 30 Germany Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 31 France Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 32 France Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 33 France Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 34 France Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 35 Italy Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 36 Italy Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 37 Italy Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 38 Italy Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 39 Spain Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 40 Spain Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 41 Spain Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 42 Spain Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 43 Denmark Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 44 Denmark Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 45 Denmark Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 46 Denmark Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 47 Sweden Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 48 Sweden Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 49 Sweden Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 50 Sweden Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 51 Norway Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 52 Norway Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 53 Norway Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 54 Norway Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 55 Asia Pacific Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 59 Japan Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 60 Japan Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 61 Japan Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 62 Japan Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 63 China Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 64 China Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 65 China Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 66 China Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 67 India Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 68 India Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 69 India Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 70 India Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 71 Australia Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 72 Australia Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 73 Australia Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 74 Australia Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 75 South Korea Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 76 South Korea Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 77 South Korea Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 78 South Korea Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 79 Thailand Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 80 Thailand Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 81 Thailand Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 82 Thailand Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 83 Latin America Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 84 Latin America Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 85 Latin America Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 86 Latin America Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 87 Brazil Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 88 Brazil Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 89 Brazil Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 90 Brazil Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 91 Argentina Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 92 Argentina Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 93 Argentina Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 94 Argentina Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 95 MEA Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 96 MEA Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 97 MEA Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 98 MEA Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 99 South Africa Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 100 South Africa Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 101 South Africa Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 102 South Africa Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 103 Saudi Arabia Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 104 Saudi Arabia Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 105 Saudi Arabia Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 107 UAE Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 108 UAE Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 109 UAE Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 110 UAE Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)
Table 111 Kuwait Hereditary cancer testing market, by cancer, 2018 - 2030 (USD Million)
Table 112 Kuwait Hereditary cancer testing market, by technology, 2018 - 2030 (USD Million)
Table 113 Kuwait Hereditary cancer testing market, by test type, 2018 - 2030 (USD Million)
Table 114 Kuwait Hereditary cancer testing market, by end user, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Hereditary cancer testing market: market outlook
Fig. 14 Hereditary cancer testing competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Hereditary cancer testing market driver impact
Fig. 20 Hereditary cancer testing market restraint impact
Fig. 21 Hereditary cancer testing market strategic initiatives analysis
Fig. 22 Hereditary cancer testing market: Cancer movement analysis
Fig. 23 Hereditary cancer testing market: Cancer outlook and key takeaways
Fig. 24 Hereditary cancer Testing market estimates and forecast, 2018 - 2030
Fig. 25 Hereditary cancer testing Market: Technology movement analysis
Fig. 26 Hereditary cancer testing market: Technology outlook and key takeaways
Fig. 27 Cytogenetic market estimates and forecasts, 2018 - 2030
Fig. 28 Biochemical market estimates and forecasts,2018 - 2030
Fig. 29 Molecular Testing market estimates and forecasts,2018 - 2030
Fig. 30 Hereditary cancer testing Market: Test Type movement analysis
Fig. 31 Hereditary cancer testing Market: Test Type outlook and key takeaways
Fig. 32 Predictive Testing market estimates and forecasts, 2018 - 2030
Fig. 33 Diagnostic Testing market estimates and forecasts, 2018 - 2030
Fig. 34 Hereditary cancer testing Market: End Use movement analysis
Fig. 35 Hereditary cancer testing market: End Use outlook and key takeaways
Fig. 36 Diagnostic Centers market estimates and forecasts, 2018 - 2030
Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 38 Clinics market estimates and forecasts, 2018 - 2030
Fig. 39 Global Hereditary cancer testing market: Regional movement analysis
Fig. 40 Global Hereditary cancer testing market: Regional outlook and key takeaways
Fig. 41 Global Hereditary cancer testing market share and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America, by country
Fig. 48 North America
Fig. 49 North America market estimates and forecasts, 2018 - 2030
Fig. 50 U.S.
Fig. 51 U.S. market estimates and forecasts, 2018 - 2030
Fig. 52 Canada
Fig. 53 Canada market estimates and forecasts, 2018 - 2030
Fig. 54 Mexico
Fig. 55 Mexico market estimates and forecasts, 2018 - 2030
Fig. 56 Europe
Fig. 57 Europe market estimates and forecasts, 2018 - 2030
Fig. 58 UK
Fig. 59 UK market estimates and forecasts, 2018 - 2030
Fig. 60 Germany
Fig. 61 Germany market estimates and forecasts, 2018 - 2030
Fig. 62 France
Fig. 63 France market estimates and forecasts, 2018 - 2030
Fig. 64 Italy
Fig. 65 Italy market estimates and forecasts, 2018 - 2030
Fig. 66 Spain
Fig. 67 Spain market estimates and forecasts, 2018 - 2030
Fig. 68 Denmark
Fig. 69 Denmark market estimates and forecasts, 2018 - 2030
Fig. 70 Sweden
Fig. 71 Sweden market estimates and forecasts, 2018 - 2030
Fig. 72 Norway
Fig. 73 Norway market estimates and forecasts, 2018 - 2030
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 76 China
Fig. 77 China market estimates and forecasts, 2018 - 2030
Fig. 78 Japan
Fig. 79 Japan market estimates and forecasts, 2018 - 2030
Fig. 80 India
Fig. 81 India market estimates and forecasts, 2018 - 2030
Fig. 82 Thailand
Fig. 83 Thailand market estimates and forecasts, 2018 - 2030
Fig. 84 South Korea
Fig. 85 South Korea market estimates and forecasts, 2018 - 2030
Fig. 86 Australia
Fig. 87 Australia market estimates and forecasts, 2018 - 2030
Fig. 88 Latin America
Fig. 89 Latin America market estimates and forecasts, 2018 - 2030
Fig. 90 Brazil
Fig. 91 Brazil market estimates and forecasts, 2018 - 2030
Fig. 92 Argentina
Fig. 93 Argentina market estimates and forecasts, 2018 - 2030
Fig. 94 Middle East and Africa
Fig. 95 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 96 South Africa
Fig. 97 South Africa market estimates and forecasts, 2018 - 2030
Fig. 98 Saudi Arabia
Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 100 UAE
Fig. 101 UAE market estimates and forecasts, 2018 - 2030
Fig. 102 Kuwait
Fig. 103 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 104 Market share of key market players - Hereditary cancer testing market